Newsquawk Daily US Earnings Estimates - 29th September 2026: CCL
Every headline is on the live feed 20 minutes before this site.
Panama Canal Authority increases Neopanamax daily capacity to 10 slots
Russia cuts oil and gas revenues estimate for 2026 to RUB 7.6tln from RUB 8.9tln previously
Newsquawk Daily US Earnings Estimates - 29th September 2026: CCL
SpaceX (SPCX) Starship returns to earth in the Pacific Ocean
KKR and RWE (RWE GY) reportedly to jointly bid for Uniper (UN01 GY)
On the Newsquawk feed at , 20 minutes before this page.
S&P 500
Carnival Ltd. (CCL) EPS (exp. 1.35), Revenue (exp. 8.39bln), Next Qtr. EPS (exp. 0.24), Next Qtr. Rev. (exp. 6.42bln), Current FY EPS (exp. 2.22), Current FY Rev. (exp. 27.60bln), Next FY EPS (exp. 2.59), Next FY Rev. (exp. 28.56bln) 14:15BST/09:15EDT
Context
This is a scheduled earnings preview rather than a result: the numbers given are consensus estimates, so the trade on the day is the print against these bars, with the forward guidance figures (next quarter and next fiscal year) historically mattering more for the share than the reported quarter itself. Carnival sits in the cruise complex, where prints have tended to be read across to peers in the same session, so the sector, not just the single name, re-prices on a surprise in either direction. For this group the customary swing factors have been booking curves and pricing for future sailings, onboard spend, net yield commentary, and fuel and currency assumptions, alongside the balance sheet given the debt load carried out of the shutdown era. A beat on the reported quarter paired with soft forward yield or booking language has, in past episodes of this kind, been sold rather than bought, which makes the guidance lines in the release the ones to watch. The timing shown places the call before the US cash open, leaving the reaction to play out in the pre-market and the opening range.
Related headlines
- EUROPEAN OPEN: AAPL cuts Oct iPhone 18 Pro component orders; AIR FP Sept deliveries flat Y/Y; SPCX agrees USD 8bln spectrum acquisition; ROP SW wins FDA approval for colon cancer drug; RBC expects MBG GY to issue a profit warning7 hours ago
- [MARKET ANALYSIS] European bourses supported by lower energy prices as earnings season gets underway next week5 hours ago
- Newsquawk Daily European Equity Opening News - 9th October 20268 hours ago
- US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM1 hour ago
- US PRE-MARKET MOVERS: AAPL, SPCX, DAL, HUM/ALHC, LITE2 hours ago
- US EQUITY OPEN: Stocks open higher with Nasdaq leading gains21 min ago
- Newsquawk European Market Wrap - 9th October 202624 min ago
- Week in Focus 12-16th October 2026: US CPI, US Retail Sales, Start of Q3 Earnings, China CPI, UK jobs, RBA Minutes and Aussie jobs1 hour ago
- AT&T (T) offers up to USD 1,200 off iPhone duo with eligible trade-in3 hours ago
- Delta Air Lines Inc. (DAL) Q3 2026 (USD): EPS 1.72 (exp. 1.76), Revenue 20.2bln (exp. 18.92bln). Current FY EPS 5.10-5.60 (exp. 5.43)3 hours ago
- Humana (HUM) affirms FY26 adj. EPS guidance of at least USD 9.004 hours ago
- [MARKET ANALYSIS] USTs a touch lower, whilst Bunds and Gilts benefit from easing energy prices4 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks trade mixed following the tech selling on Wall St10 hours ago
- European Equity pre-Market Summary – 9th October 2026: European bourses set for a firmer open8 hours ago
- Micron (MU) says it plans to construct new fabrication facilities and/or ramp production at existing fabrication facilities to increase supply in to respond to a significant increase in demand for memory products1 hour ago
- GlobalFoundries (GFS) unveils FDX Fusion FD-SOI platform for physical AI2 hours ago
- Netflix (NFLX) restructuring to impact roughly 5% employees and could be announces as early as next week, Puck reports citing sources2 hours ago
- Delta (DAL) CEO says it was a challenging quarter due to 60% rise in fuel costs, but maintained overall profitability; prices will rise further in Q43 hours ago
- Johnson & Johnson (JNJ) says 2-year ICOTYDE data in moderate-to-severe plaque psoriasis showed sustained efficacy through week 1123 hours ago
- Eli Lilly (LLY) announces new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound in adults with Psoriasis and Obesity3 hours ago
The feed had this first.
Use the Platform